Determination of toll-like receptor-induced cytokine profiles in the blood and cerebrospinal fluid of Chikungunya patients

NeuroImmunoModulation

Volumn 21, Issue 6, 2014, Pages 338-346

  Kashyap, Rajpal Singh ^a   Morey, Shweta ^a   Bhullar, Shradha ^a   Baheti, Neeraj ^a   Chandak, Nitin ^a   Purohit, Hemant ^b   Taori, Girdhar ^a   Daginawala, Hatim ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

Chikungunya; Cytokines; Neurological complications; Toll like receptors

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN; CXCL9 CHEMOKINE; INTERLEUKIN 12P35;

ADULT; ARTICLE; CASE CONTROL STUDY; CHIKUNGUNYA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROLOGICAL COMPLICATION; NUCLEOTIDE SEQUENCE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; AGED; BLOOD; CEREBROSPINAL FLUID; CHIKUNGUNYA ALPHAVIRUS; COMPLICATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PATHOGENICITY; VERY ELDERLY; BLOOD ANALYSIS; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PROTOCOL; COMPARATIVE STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HEMATOLOGICAL PARAMETERS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CYTOKINES; HUMANS; IMMUNOGLOBULINS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; TOLL-LIKE RECEPTORS;

EID: 84906940256     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000358240     Document Type: Article

References (40)

1. Vassilopoulos D, Calabrese LH: Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008; 10: 215.
2. Kamath S, Das AK, Parikh FS: Chikungunya. J Assoc Physicians India 2006; 54: 725-726.
3. Robinson MC: An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg 1955; 49: 28-32.
4. Lumsden WH: An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg 1955; 49: 33-57.
5. Pastorino B, Muyembe-Tamfum JJ, Bessaud M, Tock F, Tolou H, Durand JP, Peyrefitte CN: Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain. J Med Virol 2004; 74: 77-82.
6. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S: A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3:e201.
7. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Bréhin AC, Cubito N, Desprès P, Kunst F, Rey FA, Zeller H, Brisse S: Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006; 3:e263.
8. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V, Onyango C, Konongoi LS, Sang R, Njenga MK, Breiman RF: Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg 2007; 76: 1189-1193.
9. Fabrice S, Emilie J, Manuela O, Isabelle LG, Catherine M: Chikungunya virus infection. Curr Infect Dis Rep 2011; 13: 218-228.
10. Leo YS, Chow AL, Tan LK, Lye DC, Lin L, Ng LC: Chikungunya outbreak, Singapore, 2008. Emerg Infect Dis 2009; 15: 836-837.
11. Schwarz NG, Girmann M, Randriamampionona N, Bialonski A, Maus D, Krefis AC, Njarasoa C, Rajanalison JF, Ramandrisoa HD, Randriarison ML, May J, Schmidt-Chanasit J, Rakotozandrindrainy R: Seroprevalence of antibodies against Chikungunya, dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar. Emerg Infect Dis 2012; 18: 1780-1786.
12. Lahariya C, Pradhan SK: Emergence of Chikungunya virus in Indian subcontinent after 32 years: a review. J Vector Borne Dis 2006; 43: 151-160.
13. Lakshmi V, Neeraja M, Subbalaxmi MV, Parida MM, Dash PK, Santhosh SR, Rao PV: Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin Infect Dis 2008; 46: 1436-1442.
14. Mourya DT, Thakare JR, Gokhale MD, Powers AM, Hundekar SL, Jayakumar PC, Bondre VP, Shouche YS, Padbidri VS: Isolation of Chikungunya virus from Aedes aegypti mosquitoes collected in the town of Yawat, Pune District, Maharashtra State, India. Acta Virol 2001; 45: 305-309.
15. Jadhav M, Namboodripad M, Carman RH, Carey DE, Myers RM: Chikungunya disease in infants and children in Vellore: a report of clinical and haematological features of virologically proved cases. Indian J Med Res 1965; 53: 764-776.
16. Thiruvengadam KV, Kalyanasundaram V, Rajgopal J: Clinical and pathological studies on Chikungunya fever in Madras city. Indian J Med Res 1965; 53: 729-744.
17. Kannan M, Rajendran R, Sunish IP, Balasubramaniam R, Arunachalam N, Paramsivan R, Tewari SC, Samuel PP, Tyagi BK: A study on Chikungunya outbreak during 2007 in Kerala, south India. Indian J Med Res 2009; 129: 311-315.
18. Chandak NH, Kashyap RS, Kabra D, Karandikar P, Saha SS, Morey SH, Purohit HJ, Taori GM, Daginawala HF: Neurological complications of Chikungunya virus infection. Neurol India 2009; 57: 177-180.
19. Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, Ng LC, Ooi EE, Choo KH, Her Z, Kourilsky P, Leo YS: IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One 2009; 4:e4261.
20. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, Cavrini F, Pierro A, Rossini G, Cameron MJ, Bermejo-Martin JF, Paquette SG, Xu L, Danesh A, Farooqui A, Borghetto I, Kelvin DJ, Sambri V, Rubino S: Inflammatory cytokine expression is associated with Chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 2011; 5:e1279.
21. Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Barkham T, Yang H, Rénia L, Leo YS, Ng LF: Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 2011; 203: 149-157.
22. Chaaitanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP, Manimunda SP, Ghosal SR, Muthumani K, Vijayachari P: Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 2011; 24: 265-271.
23. Kashyap RS, Morey SH, Chandak NH, Purohit HJ, Taori GM, Daginawala HF: Detection of viral antigen, IgM and IgG antibodies in cerebrospinal fluid of Chikungunya patients with neurological complications. Cerebrospinal Fluid Res 2010; 7: 12.
24. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CM: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012; 109:E2110-E2116.
25. Lee YR, Su CY, Chow NH, Lai WW, Lei HY, Chang CL, Chang TY, Chen SH, Lin YS, Yeh TM, Liu HS: Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res 2007; 126: 216-225.
26. John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, Idro R, Byarugaba J, Boivin MJ: Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg 2008; 78: 198-205.
27. Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M: A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008; 4:e29.
28. Austin PJ, Moalem-Taylor G: The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010; 229: 26-50.
29. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A: Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003; 54: 287-296.
30. Machelska H, Stein C: Pain control by immune-derived opioids. Clin Exp Pharmacol Physiol 2000; 27: 533-536.
31. Ali Ou Alla S, Combe B: Arthritis after infection with Chikungunya virus. Best Pract Res Clin Rheumatol 2011; 25: 337-346.
32. Lee VJ, Chow A, Zheng X, Carrasco LR, Cook AR, Lye DC, Ng LC, Leo YS: Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012; 6:e1786.
33. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Bales RA, Ethisham A, Greenberg RN, Berger JR: Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol 2004; 10: 223-232.
34. Chou S, Dix RD: Viral infections and the blood-brain barrier; in Neuwelt EA (ed): Implications of the Blood-Brain Barrier and Its Manipulation, vol 2: Clinical Aspects. New York, Plenum, 1989, pp 449-468.
35. Rapoport SI: Pathological Alterations of the Blood-Brain Barrier: Blood-Brain Barrier in Physiology and Medicine. New York, Raven, 1976, pp 129-152.
36. Wispelwey B, Lesse AJ, Hansen EJ, Scheld WM: Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest 1988; 82: 1339-1346.
37. Quagliarello VJ, Wispelwey B, Long WJ Jr, Scheld WM: Recombinant human interleukin- 1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991; 87: 1360-1366.
38. Sharief MK, Ciardi M, Thompson EJ, Sorice F, Rossi F, Vullo V, Cirelli A: Tumour necrosis factor-α mediates blood-brain barrier damage in HIV-1 infection of the central nervous system. Mediators Inflamm 1992; 1: 191-196.
39. Spindler KR, Hsu T-H: Viral disruption of the blood-brain barrier. Trends Microbiol 2012; 20: 282-290.
40. Omura K, Ohbayashi M, Sano M, Omura T, Hasegawa T, Nagano A: The recovery of blood-nerve barrier in crush nerve injury - a quantitative analysis utilizing immunohistochemistry. Brain Res 2004; 1001: 13-21.